As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how ...

State Medicaid leaders create a plan to ensure safety, affordability, and equitable access for children and families living ...

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, ...

In the second part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains ...

Analysis compares care quality and efficiency within physician groups that treat Medicare Advantage patients under at-risk ...

In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical trials, key opinion leaders emphasize finding cost-effective approaches, ...

In the first part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses ...

In the final part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, describes what meaningful ...

Leading stakeholders in the industry react to how evolving US policies, payer demands, and vertical integration are reshaping ...

Future-Proofing Hubs is a Must. With ongoing policy uncertainty, hubs must prioritize adaptable, resilient designs—focusing ...

How CRO Partnerships Are Evolving to Meet Changing Industry Demands. In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech, emphasized the need for CRO ...